Radical Surgery for Gastric Carcinoma: It is Not an Issue of Whether to Perform D1 or D2. Dissect as Many Lymph Nodes as Possible and You Will Be Rewarded

References

• Kamangar F., Dores G. M., Anderson W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 2006, 24: 2137–50.
   Google Scholar
• Van Cutsem E., Van De Velde e., Roth A. et al. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal group. Eur J Cancer, 2008, 44: 182–94.
   Google Scholar
• MacDonald J., Smalley S., Benedetti J. et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Eng J Med, 2001, 345: 725–30.
   Google Scholar
• Cunningham D., Allum W. H., Stenning S. P. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 2006, 355: 11–20.
   Google Scholar
• Cunningham D., Starling N, Rao S. et al. Capecitabine and oxali-platin for advanced esophagogastric cancer. N Engl J Med, 2008, 358: 36–46.
   Google Scholar
• Sakuramoto S., Sasako M., Yamaguchi T. et al. Adjuvant chemotherapy for gastric cancer with S-1, and oral fluoropyrimi-dine. N Engl J Med, 2007, 357: 1810–20.
   Google Scholar
• Nakajima T., Kinoshita T., Nashimoto A. et al. Randomiazed controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg, 2007, 94: 1468–76.
   Google Scholar
• KoderaY., Schwarz R. E., Nakao A. Extended lymph node dissection in gastric carcinoma: Where do we stand after the Dutch and British randomized trials ? J Am Coll Surg, 2002, 195: 855–64.
   Google Scholar
• Gervasoni Jr. J. E., Sbayi S., Cady B. Role of lymphadenectomy in surgical treatment of solid tumors: An update on the clinical data. Ann Surg Oncol, 2007, 14: 2443–62.
   Google Scholar
• McNeer G., Lawrence W., Ortega L. G. et al. Early results of extended total gastrectomy for cancer. Cancer 1956, 9: 11531159.
   Google Scholar
• Jinnai D. Evaluation of extended radical operation for gastric cancer, with regard to lymph node metastasis and follow-up results. Jpn J Cancer Res 1968, 3: 225–31.
   Google Scholar
• Japanese Research Society for Gastric Cancer. Japanese Classification for Gastric Carcinoma-2"a English Edition. Gastric Cancer 1998, 1: 10–24.
   Google Scholar
• Degiuli M., Vendrame A., Muzio S., Sasako M., Maruyama K. The standard D2 gastrectomy for advanced gastric cancer. In: Degiuli M. eds. Management of gastric cancer: Recent advances. Turin: Minerva Medica, 2008: 177–194.
   Google Scholar
• Kodera Y., Nakao A. Extended surgery (D3) for advanced gastric cancer. In: Degiuli M. eds. Management of gastric cancer: Recent advances. Turin: Minerva Medica, 2008: 213–222.
   Google Scholar
• Siewert J. R., Böttcher K., Stein H. J. et al. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 1998, 228: 449–61.
   Google Scholar
• Maehara Y., Hasuda S., Koga T. et al. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg, 2000, 87: 353–7.
   Google Scholar
• Yoo C. H., Noh S. H., Shin D. W. et al. Recurrence following curative resection for gastric carcinoma. Br J Surg, 2000, 87: 23642.
   Google Scholar
• Sasako M., McCulloch P., Kinoshita T., Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995, 82: 346–51.
   Google Scholar
• Scartozzi M., Galizia E., Graziano F. et al. Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients. Br J Cancer, 2005, 92: 1051–4.
   Google Scholar
• Kodera Y., Yamamura Y., Torii A. et al. Postoperative staging of gastric carcinoma. Scand J Gastroenterol 1996, 31: 476–80.
   Google Scholar
• Roukos D. H., Lorenz M., Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer base on a new concept: A. prospective long-term follow-up study. Surgery, 1998, 123: 573–578.
   Google Scholar
• Bollschweiler E., Boettcher K., Hoelscher A. H. et al. Is the prognosis for Japanese and German patients with gastric cancer really different ? Cancer 1993, 71 :2918–25.
   Google Scholar
• Cuschieri A., Weeden S., Fielding J. et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999, 79: 1522–30.
   Google Scholar
• Bonenkamp J. J., Hermans J., Sasako M. et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999, 340: 908–14.
   Google Scholar
• Sasako M. Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 1997, 84 .1567–71.
   Google Scholar
• Hartgrink H. H., Van De Velde C. J., Putter H. et al. Extended lymph node dissection for gastric cabcer: who may benefit ? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol, 2004, 22: 2069–77.
   Google Scholar
• McCulloch P., Niita M. E., Kazi H., Gama-Rodrigues J. J. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg, 2005, 92: 5–13.
   Google Scholar
• Wu C. W., Hsiung C. A., Lo S. S. et al. Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol, 2006, 7: 309–15.
   Google Scholar
• Lee J. H., Ryu K. W., Lee J.-H. et al. Learning curve for total gastrectomy with D2 lymph node dissection: Cumulative sum analysis for qualified surgery. Ann Surg Oncol, 2006, 13: 1175–81.
   Google Scholar
• Baba M., Hokita S., Natsugoe S. et al. Paraaortic lymphadenecto-my in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterol, 2000, 33: 893–896.
   Google Scholar
• Kunisaki C., Shimada H., Yamaoka H. et al. Indication for paraaor-tic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement. Hepatogastroenterol, 2000, 47 :586–589.
   Google Scholar
• Isozaki H., Okajima K., Fujii K. et al. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterol, 1999, 46 :549–54.
   Google Scholar
• Takashima S., Kosaka T. Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer. Surg Today, 2005, 35: 425–31.
   Google Scholar
• Sano T., Sasako M., Yamamoto S. et al. Gastric cancer surgery: results of morbidity and mortality of a prospective randomized controlled trial (JC0G9501) comparing D2 and extended para-aortic lymphadenectomy. J Clin Oncol, 2004, 22: 2767–73.
   Google Scholar
• Sasako M., Sano T., Yamamoto S. et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med, 2008, 359: 453–62.
   Google Scholar
• Kodera Y., Sasako M., Yamamoto S. et al. Identification of risk factors for the development of cimplications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg, 2005, 92: 1103–9.
   Google Scholar
• Yonemura Y., Wu C. C., Fukushima N. et al. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy. Hepatogastroenterol, 2007, 54: 634–8.
   Google Scholar
• Kunisaki C., Akiyama H., Nomura M. et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol, 2006, 13: 659–67.
   Google Scholar
• Kulig J., Popiela T., Kolodziejczyk P. et al. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg, 2007, 193: 10–15.
   Google Scholar
• Nomura E., Sasako M., Yamamoto S. et al. Risk factors for para-aortic lymph node metastasis of gastric cancer from a randomized controlled trial of JC0G9501. Jpn J Clin Oncol, 2007, 38: 429–33.
   Google Scholar
• Japan Gastric Cancer Association. Gastric Cancer Treatment Guidelines. Tokyo: Kanehara Shuppan, 2001 (in Japanese: a synopsis in English is available at www.jgca.jp/PDFfiles/).
   Google Scholar
• Okinaga K., Iinuma H., Kitamura Y. et al. Effect of immunothera-py and spleen preservation on immunological function in patients with gastric cancer. J Exp Clin Cancer Res, 2006, 25: 339–49.
   Google Scholar
• Weitz J., Jacques D. P., Brennan M., Karpeh M. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer. Ann Surg Oncol, 2004, 11: 682–9.
   Google Scholar
• Katai H., Yoshimura K., Fukagawa T. et al. Risk factors for pancreas-related absecess after total gastrectomy. Gastric Cancer, 2005, 8: 137–41.
   Google Scholar
• Fatouros M., Roukos D. H., Lorenz M. et al. Impact of spleen preservation in patients with gastric cancer. Anitcancer Res, 2005, 25: 3023–30.
   Google Scholar
• KoDERA Y., Yamamura Y., Shimizu Υ. et al. Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma. World J Surg 1997, 21 :622–8.
   Google Scholar
• Kunisaki C., Makino H., Suwa H. et al. Impact of splenectomy in patients with gastric adenocarcinoma of the cardia. J Gastointesti Surg, 2007, 11: 1039–44.
   Google Scholar
• Zhang C. H., Zhang W. H., He Y. L. et al. Spleen preservation in radical surgery for gastric cardia cancer. Ann Surg Oncol, 2007, 14: 1312–9.
   Google Scholar
• Shen J. G., Cheong J. H., Hhyung W. J. et al. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am J Surg, 2006, 192: 301–5.
   Google Scholar
• Lee K. Y., Noh S. H., Hyung W. J. et al. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann Surg Oncol, 2002, 8 :402–6.
   Google Scholar
• KwON S. J. Prognostic impact of splenectomy on gastric cancer: results of the Korean Gastric Cancer Study Group. World J Surg 1997, 21 :837–44.
   Google Scholar
• Yamamoto M., Baba H., Kakeji Y. et al. Postoperative morbidity/mortality and survival rates after total gastrectomy, with splenecto-my/pancreaticosplenectomy for patients with advanced gastric cancer. Hepatogastroenterol, 2004, 51: 298–302.
   Google Scholar
• Yu W., Choi G. S., Chung H. Y. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg, 2006, 93: 559–63.
   Google Scholar
• Sano T., Yamamoto S., Sasako M. et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan Clinical Oncology Group Study JCOG0110-MF. Jpn J Clin Oncol, 2002, 32: 363–364.
   Google Scholar
• Maruyama K., Sasako M., Kinoshita T., Sano T., Katai H., Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995, 19: 532–6.
   Google Scholar
• Nobuoka D., Gotohda N., Konishi M., Nakagohri T., Takahashi S., Kinoshita T. Prevention of postoperative pancreatic fistula after total gastrectomy. World J Surg, 2008, 32: 2261–6.
   Google Scholar
• Shrikhande S. V., Shukla P. L., Qureshi S. et al. D2 lymphadenec-tomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg, 2006, 23: 192–7.
   Google Scholar
• Sasagawa T., Solano H., Vega W., Mena F. The effectiveness of extended lypm node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan. Am J Surg, 2008, 195: 5360.
   Google Scholar
• Collard J.-M., Malaise J., Marbut J.-Y., Kestens P.-J. Skeletonizing en-bloc gastrectomy for adenocaricnoma in Caucasian patients. Gastric Cancer, 2003, 6: 210–6.
   Google Scholar
• Sierra A., Regueria F. M., Hernandez-Lizoain J. L. et al. Role of the extended lymphadenectomy in gastric cancer surgery: Experience in a single institution. Ann Surg Oncol, 2003, 10: 21926.
   Google Scholar
• Portanova M., Vargas F., Lombardi E. et al. Results of specialization in the surgical treatment of gastric cancer in Peru. Gastric Cancer, 2007, 10: 92–7.
   Google Scholar
• Diaz De Liano A., Yarnoz C., Aguilar R., Artieda C., Ortiz H. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer, 2008, 11: 96–102.
   Google Scholar
• Edwards P., Blackshaw G. R. J. C., Lewis W. G., Barry J. D., Allison M. C., Jones D. R. B. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer, 2004, 90: 1888–92.
   Google Scholar
• Biffi R., Chiappa A., Kuca F. et al. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in as single center series of 250 patients. J Surg Oncol, 2006, 93: 394–400.
   Google Scholar
• Degiuli M., Sasako M., Calgaro M. et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomized surgical trial. Eur J Surg Oncol, 2004, 30: 303–8.
   Google Scholar
• Hundahl S. A., MacDonald J. S., Benedetti J. et al. Surgical treatment variation in a prospective, randomized trial of chemo-radiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol, 2002, 9: 278–86.
   Google Scholar
• Siewert J. R., Kelsen D., Maruyama K. et al. Gastric cancer diagnosis and treatment-an interactive training program. New York: Springer Electronic Media, 2000.
   Google Scholar
• Peeters K. C. M. J., Hundahl S. A., Kranenbarg E. K., Hartgrink H., Van De Velde C. J. J. Low Maruyama Index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg, 2005, 29: 1576–84.
   Google Scholar
• Hundahl S. A., Peeters K. C. M. J., Kranenbarg E. K., Hartgrink H., Van De Velde C. J. H. Improved regional control and survival with “low Maruyama Index” surgery in gastric cancer: autopsy findings from the Dutch D1-D2 trial. Gastric Cancer, 2007, 10: 84–86.
   Google Scholar
• Smith D. D., Schwarz R. R., Schwarz R. E. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: Data from a large US-population database. J Clin Oncol, 2005, 28: 7114–24.
   Google Scholar
• Kattan N. W., Karpeh M. S., Mazumdar M., Brennan M. F. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol, 2003, 21: 3647–50.
   Google Scholar
• Peeters K. C., Kattan M. W., Hartgrink H. H., Kranenbarg E. K., Karpeh M. S., Brennan M. F., Van De Velde C. J. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer, 2005, 103: 702–7.
   Google Scholar
• Novotony A. R., Schuhmacher C., Busch R., Kattan M. W., Brennan M. F., Siewert J. R. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe. Ann Surg, 2006, 243: 74–81.
   Google Scholar
• Ajani J. A. Operate on my stomach cancer ? Oh, no-Not you, or not yet ! J Clin Oncol, 2004, 22: 1763–4.
   Google Scholar
• Schwarz R. E., Smith D. D. Extended lymph node dissection for gastric cancer: Who may benefit ? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol, 2005, 23: 5404.
   Google Scholar
• Pramesh C. S., Kulkarni N. N., Mistry R. C., Badwe R. A. Lymphadenectomy in cancer: time for a paradigm shift ? Lancet Onol, 2006, 7: 450–1.
   Google Scholar